Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study to Evaluate Retreatment With LIPO-202

NCT02397525 is registered in ClinicalTrials.gov with Neothetics, Inc as lead sponsor.

NCT NCT02397525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02397525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study to Evaluate Retreatment With LIPO-202
Lead sponsor
Neothetics, Inc
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2015
Completion date
Not reported
Enrollment
150 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

central abdominal bulging